Nicola Gervasoni

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation
    N Gervasoni
    Departement de Psychiatrie, Clinique de Psychiatrie Adulte Programme Dépression, Hopitaux Universitaires de Geneve, Domaine de Belle Idée, 16 18, bd Saint Georges, CH 1205 Geneva, Switzerland
    Pharmacol Res 48:649-53. 2003
  2. ncbi Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode
    Nicola Gervasoni
    Adult Psychiatric Service, Department of Psychiatry, Geneva University Hospital, 16 18 bd Saint Georges, 1205 Geneva, Switzerland
    J Psychiatr Res 38:553-7. 2004
  3. ncbi Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode
    Nicola Gervasoni
    Department of Psychiatry, Geneva University Hospital, 16 18 boulevard Saint Georges, CH 1205 Geneva, Switzerland
    Neuropsychobiology 51:234-8. 2005
  4. ncbi [Trends in psychiatry]
    Nicola Gervasoni
    Service de Psychiatrie Adulte, HUG, Geneve
    Rev Med Suisse 4:158-60, 162-5. 2008
  5. doi CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response
    Marianne Gex-Fabry
    Division of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Chene Bourg, Switzerland
    Ther Drug Monit 30:474-82. 2008
  6. ncbi The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
    Jean Michel Aubry
    Department of Psychiatry, Adult Psychiatric Service Secteur 2, 16 18 Boulevard St Georges, CH 1205 Geneva, Switzerland
    J Psychiatr Res 41:290-4. 2007
  7. doi Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity
    Nicola Gervasoni
    Service of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Switzerland
    Eur Psychiatry 24:341-4. 2009
  8. doi The cortisol awakening response in patients remitted from depression
    Jean Michel Aubry
    Department of Psychiatry, Geneva University Hospital, Bipolar Program, 6 8 rue du 31 Décembre, 1207 Geneva, Switzerland
    J Psychiatr Res 44:1199-204. 2010
  9. ncbi Time course of response to paroxetine: influence of plasma level
    Marianne Gex-Fabry
    Service of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, 2 Chemin du Petit Bel Air, CH 1225 Chene Bourg, Switzerland
    Prog Neuropsychopharmacol Biol Psychiatry 31:892-900. 2007
  10. doi Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects
    Eva Choong
    Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, University Hospital Centre and University of Lausanne, Prilly, Switzerland
    J Clin Psychopharmacol 33:289-98. 2013

Detail Information

Publications12

  1. ncbi Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation
    N Gervasoni
    Departement de Psychiatrie, Clinique de Psychiatrie Adulte Programme Dépression, Hopitaux Universitaires de Geneve, Domaine de Belle Idée, 16 18, bd Saint Georges, CH 1205 Geneva, Switzerland
    Pharmacol Res 48:649-53. 2003
    ..Although there was no control group, the prediction test often allowed us to use a higher dose than the usual fixed dose whose amount is limited by the risk of overdosing for the slower metabolizers...
  2. ncbi Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode
    Nicola Gervasoni
    Adult Psychiatric Service, Department of Psychiatry, Geneva University Hospital, 16 18 bd Saint Georges, 1205 Geneva, Switzerland
    J Psychiatr Res 38:553-7. 2004
    ..In future studies, it could be interesting to use this test more specifically by dividing ambulatory patients into subgroups according to their past depressive history. It could also be interesting to measure the ACTH level...
  3. ncbi Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode
    Nicola Gervasoni
    Department of Psychiatry, Geneva University Hospital, 16 18 boulevard Saint Georges, CH 1205 Geneva, Switzerland
    Neuropsychobiology 51:234-8. 2005
    ..These results suggest that antidepressant treatment has a positive effect on serum BDNF levels and support the hypothesis of neurotrophic factor involvement in affective disorders...
  4. ncbi [Trends in psychiatry]
    Nicola Gervasoni
    Service de Psychiatrie Adulte, HUG, Geneve
    Rev Med Suisse 4:158-60, 162-5. 2008
    ..3) The potential efficacy of dawn simulation and high density negative air ionization in seasonal depression...
  5. doi CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response
    Marianne Gex-Fabry
    Division of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Chene Bourg, Switzerland
    Ther Drug Monit 30:474-82. 2008
    ..The hypothesis that permeability glycoprotein activity might be a relevant predictor of therapeutic response deserves to be further investigated while controlling for pharmacokinetic variability...
  6. ncbi The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
    Jean Michel Aubry
    Department of Psychiatry, Adult Psychiatric Service Secteur 2, 16 18 Boulevard St Georges, CH 1205 Geneva, Switzerland
    J Psychiatr Res 41:290-4. 2007
    ..These results suggest that in outpatients who are in clinical remission from a major depressive episode, high delta and AUC values in the DEX/CRH test compared to controls subjects can be associated with a higher risk of relapse...
  7. doi Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity
    Nicola Gervasoni
    Service of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Switzerland
    Eur Psychiatry 24:341-4. 2009
    ....
  8. doi The cortisol awakening response in patients remitted from depression
    Jean Michel Aubry
    Department of Psychiatry, Geneva University Hospital, Bipolar Program, 6 8 rue du 31 Décembre, 1207 Geneva, Switzerland
    J Psychiatr Res 44:1199-204. 2010
    ..007), while a 21% AUC decrease was associated with a 1-h longer sleep duration (p<0.001). In future studies, detection of between-group differences might benefit from adjusting for sleep duration and other possible confounders...
  9. ncbi Time course of response to paroxetine: influence of plasma level
    Marianne Gex-Fabry
    Service of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, 2 Chemin du Petit Bel Air, CH 1225 Chene Bourg, Switzerland
    Prog Neuropsychopharmacol Biol Psychiatry 31:892-900. 2007
    ..005). The present study supports the hypothesis that higher paroxetine concentration might contribute to hasten relief of depressive symptoms in severely depressed patients...
  10. doi Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects
    Eva Choong
    Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, University Hospital Centre and University of Lausanne, Prilly, Switzerland
    J Clin Psychopharmacol 33:289-98. 2013
    ..This is the first report on the influence of NR1/2 polymorphisms on RLAI exposure and on drug-induced adverse effects. These results should be validated in larger cohorts...
  11. ncbi Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ)
    Béatrice Weber Rouget
    Programme bipolaire, Secteur 2 Jonction, Departement de Psychiatrie, HUG, Geneva, Switzerland
    J Affect Disord 88:103-8. 2005
    ..Modifications of its criteria for a positive screening as well as its test-retest reliability are also addressed...
  12. ncbi Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
    Felicien Karege
    Service of Neuropsychiatry, Geneva University Hospitals Belle Idée, Chêne Bourg Geneva, Switzerland
    Biol Psychiatry 57:1068-72. 2005
    ..Decreased serum BDNF levels have been reported in major depression, but the cause of this decrease has not yet been investigated. The goal of this study was to assess blood BDNF and a platelet activation index, PF4...